Belite Bio, Inc Belite Bio, Inc

Belite Bio, Inc

BLTE

Rang în acțiuni #3051
Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the... Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targets various liver ailments, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Founded in 2016, Belite Bio, Inc. is headquartered in San Diego, California, and operates as a subsidiary of Lin Bioscience International Ltd.
Preț acțiune
$148.24
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$5.97B
Schimbare (1 zi)
3.82%
Schimbare (1 an)
64.04%
Țară
US
Tranzacționează Belite Bio, Inc (BLTE)

Categorie

Healthcare
Istoricul spliturilor pentru Belite Bio, Inc (BLTE)
Acțiunea Belite Bio, Inc (simbol: BLTE) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 20, 2026.
O acțiune BLTE cumpărată înainte de Oct 20, 2026 este echivalentă astăzi cu 0 acțiuni BLTE.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL